Based on the available data, “oncochannels” such as KCa3.1 as well as dysregulated signaling pathways that depend on these channels may be promising candidates in the therapy of various solid tumors including, among others, glioblastoma, endometrial, prostate, breast, hepatocellular, and cervical carcinoma. The gene discussed is KCNN4; the disease is cervical carcinoma.